NCT00521417

Brief Summary

A primary goal of this study is to investigate the significance of treatment duration, by comparing change after group psychotherapy of varying lengths. A secondary goal is to investigate the predictive value of selected patient variables on outcome: personality pathology, quality of object relations, presence of personality disorder, degree of initial disturbance, and education. One hundred and twenty patients from 5-6 different study sites (consisting of one coordinator and 3 therapists) will be included. Exclusion criteria are psychosis, substance abuse, and organically based symptoms. Patients are interviewed before treatment and one year after termination, and self-rated outcome measures are filled in at 3-month intervals during treatment and at termination. After an initial evaluation, patients are randomized to one of two manualized psychodynamic group psychotherapies with different treatment lengths (20 and 80 sessions). Each therapist will conduct both a short- and a long-term group, and sessions are taped in order to check treatment integrity.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
140

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Aug 2005

Longer than P75 for phase_2

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2005

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

August 24, 2007

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 27, 2007

Completed
10.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2018

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2020

Completed
Last Updated

May 2, 2016

Status Verified

April 1, 2016

Enrollment Period

13 years

First QC Date

August 24, 2007

Last Update Submit

April 29, 2016

Conditions

Keywords

RCT

Outcome Measures

Primary Outcomes (1)

  • scl-90-R, IIP-C, GAF

    before and after therapy,follow-up and every 3 months during therapy

Study Arms (2)

short-term dynamic therapy

EXPERIMENTAL

Group therapy 20 sessions, give insight

Behavioral: short-term dynamic therapy

long-term dynamic therapy

ACTIVE COMPARATOR

Group therapy 80 sessions, give insight

Behavioral: long-term dynamic therapy

Interventions

short-term dynamic therapy
long-term dynamic therapy

Eligibility Criteria

Age20 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who consult or are referred to oupatient psychiatric centers or private pratice, and who are considered suitable for ambulant psychodynamic group psychotherapy.

You may not qualify if:

  • Active psychotic disorder, drug or alcohol dependence as main diagnosis, organically based symptoms, e.g. brain damage, autism and adult ADHD.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Distriktpsykiatrisk senter Helse sunnmøre

Ålesund, Ålesund, 6014, Norway

Location

Related Publications (2)

  • Storebo OJ, Stoffers-Winterling JM, Vollm BA, Kongerslev MT, Mattivi JT, Jorgensen MS, Faltinsen E, Todorovac A, Sales CP, Callesen HE, Lieb K, Simonsen E. Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev. 2020 May 4;5(5):CD012955. doi: 10.1002/14651858.CD012955.pub2.

  • Lorentzen S, Ruud T, Fjeldstad A, Hoglend P. Comparison of short- and long-term dynamic group psychotherapy: randomised clinical trial. Br J Psychiatry. 2013 Sep;203(3):280-7. doi: 10.1192/bjp.bp.112.113688. Epub 2013 Sep 12.

MeSH Terms

Conditions

Mood DisordersAnxiety DisordersPersonality Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

  • Steinar Lorentzen, Dr. med.

    Associate Professor University of Oslo

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
professor emeritus

Study Record Dates

First Submitted

August 24, 2007

First Posted

August 27, 2007

Study Start

August 1, 2005

Primary Completion

August 1, 2018

Study Completion

August 1, 2020

Last Updated

May 2, 2016

Record last verified: 2016-04

Locations